| Literature DB >> 18922462 |
Paul H Huang1, Forest M White.
Abstract
In recent years, phosphoproteomic technologies have increased our understanding of cellular signaling networks. Here, we frame recent phosphoproteomics-based advances in the context of the DNA damage response and ErbB receptor family signaling and offer a perspective on how the molecular insights arising from the integration of such proteomic approaches might be used for clinical applications.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18922462 PMCID: PMC2754874 DOI: 10.1016/j.molcel.2008.09.001
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970